Ndfip 1 regulates nuclear Pten import in vivo to promote neuronal survival following cerebral ischemia

PTEN (phosphatase and tensin homologue deleted on chromosome TEN) is the major negative regulator of signaling by phosphatidylinositol 3-kinase (PI 3-K), thereby playing a central role in controlling many important cellular activities regulated by this pathway, including cell division, cell growth, cell survival, and DNA damage (Chalhoub and Baker, 2009). PTEN exerts its negative effect through its phosphatase activity on the plasma membrane lipid phosphatidylinositol 3,4,5-triphosphate (PIP3), reducing levels of phosphorylated Akt (pAkt; Maehama and Dixon, 1998; Stambolic et al., 1998). Thus, loss of PTEN, as demonstrated by genetic inactivation in human cancer or mouse knockout (KO) models, causes constitutive activation of Akt in cells, resulting in dysregulated cell proliferation, growth, and survival, which are hallmarks of tumorigenesis (Hobert and Eng, 2009; Nardella et al., 2010). PTEN can be found in both the cytoplasm and nucleus of many cell and tissue types, and its aberrant localization has been implicated in disease. The nucleocytoplasmic distribution of PTEN has been proposed to affect its tumorsuppressive function both within and outside the PI 3-K pathway (Planchon et al., 2008). However, it has remained unclear what physiological stimulus can drive PTEN into the nucleus and under what in vivo circumstances this can occur. In the brain, PTEN is required for multiple aspects of neuronal function and development, including maintenance of neuron structure, size, synaptic plasticity, and survival (Endersby PTEN (phosphatase and tensin homologue deleted on chromosome TEN) is the major negative regulator of phosphatidylinositol 3-kinase signaling and has cell-specific functions including tumor suppression. Nuclear localization of PTEN is vital for tumor suppression; however, outside of cancer, the molecular and physiological events driving PTEN nuclear entry are unknown. In this paper, we demonstrate that cytoplasmic Pten was translocated into the nuclei of neurons after cerebral ischemia in mice. Critically, this transport event was dependent on a surge in the Nedd4 family–interacting protein 1 (Ndfip1), as neurons in Ndfip1-deficient mice failed to import Pten. Ndfip1 binds to Pten, resulting in enhanced ubiquitination by Nedd4 E3 ubiquitin ligases. In vitro, Ndfip1 overexpression increased the rate of Pten nuclear import detected by photobleaching experiments, whereas Ndfip1/ fibroblasts showed negligible transport rates. In vivo, Ndfip1 mutant mice suffered larger infarct sizes associated with suppressed phosphorylated Akt activation. Our findings provide the first physiological example of when and why transient shuttling of nuclear Pten occurs and how this process is critical for neuron survival. Ndfip1 regulates nuclear Pten import in vivo to promote neuronal survival following cerebral ischemia

[1]  Pier Paolo Pandolfi,et al.  Nuclear PTEN Regulates the APC-CDH1 Tumor-Suppressive Complex in a Phosphatase-Independent Manner , 2011, Cell.

[2]  Q. Wan,et al.  Preservation of GABAA Receptor Function by PTEN Inhibition Protects Against Neuronal Death in Ischemic Stroke , 2010, Stroke.

[3]  C. Downes,et al.  Ubiquitination of PTEN (Phosphatase and Tensin Homolog) Inhibits Phosphatase Activity and Is Enhanced by Membrane Targeting and Hyperosmotic Stress* , 2010, The Journal of Biological Chemistry.

[4]  C. Holt,et al.  E3 Ligase Nedd4 Promotes Axon Branching by Downregulating PTEN , 2010, Neuron.

[5]  C. Eng,et al.  PTEN hamartoma tumor syndrome: An overview , 2009, Genetics in Medicine.

[6]  Sharad Kumar,et al.  Divalent metal transporter 1 (DMT1) regulation by Ndfip1 prevents metal toxicity in human neurons , 2009, Proceedings of the National Academy of Sciences.

[7]  D. Ferriero,et al.  Involvement of the PTEN–AKT–FOXO3a Pathway in Neuronal Apoptosis in Developing Rat Brain after Hypoxia–Ischemia , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[8]  G. Steinberg,et al.  The Protective Effect of Early Hypothermia on PTEN Phosphorylation Correlates with Free Radical Inhibition in Rat Stroke , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[9]  S. Baker,et al.  PTEN and the PI3-kinase pathway in cancer. , 2009, Annual review of pathology.

[10]  S. Baker,et al.  PTEN signaling in brain: neuropathology and tumorigenesis , 2008, Oncogene.

[11]  Xinjiang Wang,et al.  Crucial role of the C-terminus of PTEN in antagonizing NEDD4-1-mediated PTEN ubiquitination and degradation. , 2008, The Biochemical journal.

[12]  V. Stambolic,et al.  The ubiquitin ligase Nedd4-1 is dispensable for the regulation of PTEN stability and localization , 2008, Proceedings of the National Academy of Sciences.

[13]  C. Eng,et al.  The nuclear affairs of PTEN , 2008, Journal of Cell Science.

[14]  Q. Wan,et al.  Phosphatase PTEN in neuronal injury and brain disorders , 2007, Trends in Neurosciences.

[15]  Tom Misteli,et al.  Ubiquitination Regulates PTEN Nuclear Import and Tumor Suppression , 2007, Cell.

[16]  P. Pandolfi,et al.  NEDD4-1 Is a Proto-Oncogenic Ubiquitin Ligase for PTEN , 2007, Cell.

[17]  P. Pandolfi,et al.  Essential Role for Nuclear PTEN in Maintaining Chromosomal Integrity , 2007, Cell.

[18]  R. Sapolsky,et al.  Phosphoinositide-3-kinase/Akt survival signal pathways are implicated in neuronal survival after stroke , 2006, Molecular Neurobiology.

[19]  T. Beißbarth,et al.  Nedd4-WW Domain-Binding Protein 5 (Ndfip1) Is Associated with Neuronal Survival after Acute Cortical Brain Injury , 2006, The Journal of Neuroscience.

[20]  Sharad Kumar,et al.  Regulation of functional diversity within the Nedd4 family by accessory and adaptor proteins. , 2006, BioEssays : news and reviews in molecular, cellular and developmental biology.

[21]  Wei Zhang,et al.  Pten Regulates Neuronal Arborization and Social Interaction in Mice , 2006, Neuron.

[22]  J. H. Lee,et al.  Cilostazol: therapeutic potential against focal cerebral ischemic damage. , 2006, Current pharmaceutical design.

[23]  M. Fehlings,et al.  Dual Neuroprotective Signaling Mediated by Downregulating Two Distinct Phosphatase Activities of PTEN , 2004, The Journal of Neuroscience.

[24]  A. Hall,et al.  Regulation of Cell Migration by the C2 Domain of the Tumor Suppressor PTEN , 2004, Science.

[25]  N. Copeland,et al.  A highly efficient recombineering-based method for generating conditional knockout mutations. , 2003, Genome research.

[26]  C. Eng,et al.  Increased nuclear phosphatase and tensin homologue deleted on chromosome 10 is associated with G0-G1 in MCF-7 cells. , 2003, Cancer research.

[27]  William R. Sellers,et al.  Phosphorylation of the PTEN Tail Acts as an Inhibitory Switch by Preventing Its Recruitment into a Protein Complex* , 2001, The Journal of Biological Chemistry.

[28]  T. Mak,et al.  Deletion of Pten in mouse brain causes seizures, ataxia and defects in soma size resembling Lhermitte-Duclos disease , 2001, Nature Genetics.

[29]  P. Burger,et al.  Pten regulates neuronal soma size: a mouse model of Lhermitte-Duclos disease , 2001, Nature Genetics.

[30]  S. Vannucci,et al.  Experimental Stroke in the Female Diabetic, db/db, Mouse , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[31]  Susumu Tonegawa,et al.  Cortex-restricted disruption of NMDAR1 impairs neuronal patterns in the barrel cortex , 2000, Nature.

[32]  Francisca Vazquez,et al.  Phosphorylation of the PTEN Tail Regulates Protein Stability and Function , 2000, Molecular and Cellular Biology.

[33]  C. Eng,et al.  Changes in endometrial PTEN expression throughout the human menstrual cycle. , 2000, The Journal of clinical endocrinology and metabolism.

[34]  José Luis de la Pompa,et al.  Negative Regulation of PKB/Akt-Dependent Cell Survival by the Tumor Suppressor PTEN , 1998, Cell.

[35]  Tomohiko Maehama,et al.  The Tumor Suppressor, PTEN/MMAC1, Dephosphorylates the Lipid Second Messenger, Phosphatidylinositol 3,4,5-Trisphosphate* , 1998, The Journal of Biological Chemistry.

[36]  R A Swanson,et al.  A Semiautomated Method for Measuring Brain Infarct Volume , 1990, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[37]  P. Pandolfi,et al.  Faithfull modeling of PTEN loss driven diseases in the mouse. , 2010, Current topics in microbiology and immunology.